日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery

FDA批准摘要:Vorasidenib用于IDH突变型2级星形细胞瘤或少突胶质细胞瘤术后治疗

Barbato, Michael I; Barone, Amy K; Aungst, Stephanie L; Miller, Claudia P; Ananthula, Suryatheja; Bi, Youwei; Yang, Yuching; Li, Xiaoxue; Xiong, Ye; Fan, Jianghong; Dorff, Sarah E; Zhao, Hong; Zhou, Hua; Pradhan, Shan; Scepura, Barbara; Sinha, Arup K; Stephenson, Maritsa; Bhatnagar, Vishal; Saber, Haleh; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Larkins, Erin; Drezner, Nicole

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

FDA批准摘要:托沃拉非尼用于治疗复发或难治性BRAF突变型儿童低级别胶质瘤

Singh, Sonia; Bradford, Diana; Chatterjee, Somak; Li, Xiaoxue; Aungst, Stephanie L; Skinner, Amy M; Miller, Claudia P; Kim-McOlash, Sarah; Fourie Zirkelbach, Jeanne; Xiong, Ye; Bi, Youwei; Wang, Ying-Hong; Yang, Yuching; Sun, Jielin; Kraft, Jeffrey; Charlab, Rosane; Shord, Stacy S; Tang, Shenghui; Scepura, Barbara; Bulatao, Ilynn; Udoka, Opeyemi; Saber, Haleh; Rahman, Nam Atiqur; Pazdur, Richard; Singh, Harpreet; Donoghue, Martha; Drezner, Nicole

FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

FDA批准摘要:瑞波替尼用于治疗局部晚期或转移性ROS1阳性非小细胞肺癌

Barbato, Michael I; Bradford, Diana; Ren, Yi; Aungst, Stephanie L; Miller, Claudia P; Pan, Lili; Zirkelbach, Jeanne F; Li, Yangbing; Bi, Youwei; Fan, Jianghong; Grimstein, Manuela; Dorff, Sarah E; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Scepura, Barbara; Schotland, Peter; Udoka, Opeyemi; Ojofeitimi, Idara; Leighton, John K; Rahman, Nam A; Pazdur, Richard; Singh, Harpreet; Kluetz, Paul G; Drezner, Nicole

FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations

FDA批准摘要:fam-trastuzumab deruxtecan-nxki 用于治疗具有激活 HER2 突变的不可切除或转移性非小细胞肺癌

Mehta, Gautam U; Vellanki, Paz J; Ren, Yi; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Pan, Lili; Zirkelbach, Jeanne F; Pan, Yuzhuo; Liu, Jiang; Aungst, Stephanie L; Miller, Claudia P; Shah, Mirat; Rahman, Nam Atiqur; Theoret, Marc; Kluetz, Paul; Pazdur, Richard; Beaver, Julia A; Singh, Harpreet

Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis

使用降钙素基因相关肽单克隆抗体治疗多发性硬化症患者的偏头痛

Mason, Ashley; Fragapane, Lauren; Toledo-Nieves, Zuleyma; Moreo, Natalie; Aungst, Angela; Robertson, Derrick; Maldonado, Janice

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

FDA批准摘要:Amivantamab用于治疗携带EGFR 20号外显子插入突变的非小细胞肺癌患者

Chon, Katie; Larkins, Erin; Chatterjee, Somak; Mishra-Kalyani, Pallavi S; Aungst, Stephanie; Wearne, Emily; Subramaniam, Sriram; Li, Yangbing; Liu, Jiang; Sun, Jielin; Charlab, Rosane; Zhao, Hong; Saritas-Yildirim, Banu; Bikkavilli, Rama Kamesh; Ghosh, Soma; Philip, Reena; Beaver, Julia A; Singh, Harpreet

Machine learning models for rat multigeneration reproductive toxicity prediction

用于预测大鼠多代生殖毒性的机器学习模型

Liu, Jie; Guo, Wenjing; Dong, Fan; Aungst, Jason; Fitzpatrick, Suzanne; Patterson, Tucker A; Hong, Huixiao

Considerations for Applying Route-to-Route Extrapolation to Assess the Safety of Oral Exposure to Substances

应用途径间推断法评估口服接触物质安全性的注意事项

Kabadi, Shruti V; Fisher, Jeffrey; Hung, Benjamin; Aungst, Jason

Optimizing Social Support in Oncology with Digital Platforms

利用数字平台优化肿瘤科的社会支持

Katsaros, Dimos; Hawthorne, James; Patel, Jay; Pothier, Kaitlin; Aungst, Timothy; Franzese, Chris

Is it COVID-19? The value of medicolegal autopsies during the first year of the COVID-19 pandemic

是新冠肺炎吗?新冠肺炎疫情第一年法医尸检的价值

Geller, Rachel L; Aungst, Jenna L; Newton-Levinson, Anna; Smith, Geoffrey P; Mosunjac, Marina B; Mosunjac, Mario I; Cunningham, Christy S; Gowitt, Gerald T